Comment on: The national burden of infections after prostate biopsy in England and Wales: A wake-up call for better prevention

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 10, 2013, Pages 2418-2420

  Balakrishnan, Indran ^a   Smith, Gillian ^a  

^a ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antimicrobial prophylaxis; Ciprofloxacin resistance; Prostate; Temocillin

Indexed keywords

AMIKACIN; CIPROFLOXACIN; TEMOCILLIN;

ANTIBIOTIC PROPHYLAXIS; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HEALTH CARE SYSTEM; HOSPITALIZATION; HUMAN; INDWELLING URINARY CATHETER; MEDICAL SOCIETY; MONOTHERAPY; MYCOBACTERIUM; NEEDLE BIOPSY; PENICILLIN ALLERGY; POSTTRANSRECTAL ULTRASOUND GUIDED NEEDLE BIOPSY; PRACTICE GUIDELINE; PROPHYLAXIS; PROSTATE BIOPSY; PSEUDOMONAS AERUGINOSA; RECTUM BIOPSY; RISK FACTOR; SEPSIS; TRAVEL; UNITED KINGDOM; URINARY TRACT INFECTION; UROLOGY;

ANTIMICROBIAL PROPHYLAXIS; CIPROFLOXACIN RESISTANCE; PROSTATE; TEMOCILLIN;

ANTI-BACTERIAL AGENTS; BIOPSY; CHEMOPREVENTION; FLUOROQUINOLONES; HUMANS; MALE; PROSTATITIS;

EID: 84888793780     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt168     Document Type: Article

References (8)

1. Batura D, Gopal Rao G. The national burden of infections after prostate biopsy in England and Wales: a wake-up call for better prevention. J Antimicrob Chemother 2013; 68: 247-9.
2. Bratzler DW, Patchen Dellinger E, Olsen KM et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013; 70: 195-283.
3. van der Starre WE, van Nieuwkoop C, Paltansing S et al. Risk factors for fluoroquinolone-resistant Escherichia coli in adults with communityonset febrile urinary tract infection. J Antimicrob Chemother 2011; 66: 650-6.
4. Dancer D. The problem with cephalosporins. J Antimicrob Chemother 2001; 48: 463-78.
5. Florida Department of Health. Guidelines for Prevention and Control of Infections Due to Antibiotic-Resistant Organisms. 2010. http://www.doh. state.fl.us/disease_ctrl/epi/icg/GuidelinesAntibioticResistant3-5-10% 20_2_.pdf (11 February 2013, date last accessed).
6. BSAC. Bacteraemia Data, 2011. http://www.bsacsurv.org/mrsweb/bacteraemia?organism=E.%20coli&antimicrobial=cip&year=2011& country=UK&summary=SIRSummary&formname=bsac_bacteraemia& submit=Search%20(%20this%20tab%20) (15 April 2013, date last accessed).
7. Livermore DM, Tulkens PM. Temocillin revived. J Antimicrob Chemother 2009; 63: 243-5.
8. Balakrishnan I, Awad-El-Kariem FM, Aali A et al. Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC b-lactamaseproducing Enterobacteriaceae. J Antimicrob Chemother 2011; 66: 2628-31.